| Symbol | HTGMQ |
|---|---|
| Name | HTG MOLECULAR DIAGNOSTICS, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 85706 United States AZ 3430 E. Global Loop |
| Telephone | (877) 289-2615 |
| Fax | — |
| — | |
| Website | https://www.htgmolecular.com/ |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001169987 |
| Description | HTGs mission is to advance the promise of precision medicine through innovative transcriptome-wide profiling technology designed to accelerate the development of diagnostics and hasten the discovery of novel drug candidates to effect lifechanging outcomes. The companys proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery. Additional info from OTC: |
No news found.